Social phobia following maprotiline: the first case report

IntroductionIt has long been recognized that anxiety symptoms and syndromes may be caused by medication and/or substance of abuse. The aim of this report is to present a patient who experienced social phobia following maprotiline, an adverse drug reaction which has not been reported previously with this agent.Case presentationA 27 year-old male patient was suffering from dysthymia for 6 years.

He received different kinds of pharmacotherapy including TCAs, SSRIs, MAOIs. Due to his poor response, augmenting therapy with liothyronine and lithium and also cognitive therapy have been tried for him.

Since he did not respond well to these treatments, maprotiline was administered for him 50 mg daily. His psychological problems improved with maprotiline, however he experienced social phobia that has not experienced yet.

Conclusion: This could underlie the precipitation of social phobia after maprotiline.

However there is a need for further studies.

Author: Seyed Hamzeh HosseiniEbraheim Salehifar
Credits/Source: Cases Journal 2009, 2:9340

Published on: 2009-12-17

Copyright by the authors listed above - made available via BioMedCentral (Open Access). Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.

Comments Page 0 of 0

There are currently 0 comments to display.

+ Add New Comment

Custom Search